发明名称 |
NOVEL PHENYLACETAMIDE COMPOUND AND PHARMACEUTICAL CONTAINING SAME |
摘要 |
The present invention is to create a compound that selectively activates glucokinase in the liver, and in particular, to provide an agent for treating and preventing diabetes and impaired glucose tolerance, wherein the agent has a low hypoglycemia risk.;A compound represented by the formula (1) as shown below, or a salt thereof, or a solvate of the compound or the salt:;[wherein, in the following formula (1), ring A represents a thiazolyl group, a pyridyl group, a pyrazyl group, or a pyrazolyl group; L represents —(CO)—, —(CS)—, or —SO2—; and R1 represents a C1-6 alkyl group, a hydroxy C1-6 alkyl group, a C1-6 alkoxy group, an amino group, a C1-6 alkylamino group, a hydroxyamino group, an N—C1-6 alkylcarbamoyl group, or a group represented by the formula (2) as shown below, wherein R3 represents a C1-6 alkyl group; and R2 represents a hydrogen atom, a halogen atom, a C1-6 alkyl group, a C1-6 alkoxy group, or a carboxyl group].; |
申请公布号 |
US2015218151(A1) |
申请公布日期 |
2015.08.06 |
申请号 |
US201314427865 |
申请日期 |
2013.09.25 |
申请人 |
KOWA COMPANY, LTD. |
发明人 |
Ogamino Takahisa;Tanikawa Shin;Miyake Yoshiharu;Itoh Shinsuke;Sawada Yoshikazu |
分类号 |
C07D417/14;C07D403/12;C07D401/12;C07D417/12 |
主分类号 |
C07D417/14 |
代理机构 |
|
代理人 |
|
主权项 |
1. A compound represented by the following formula (1), or a salt thereof, or a solvate of the compound or the salt: wherein ring A represents a thiazolyl group, a pyridyl group, a pyrazyl group, or a pyrazolyl group, L represents —(CO)—, —(CS)—, or —(SO2)—, R1 represents a C1-6 alkyl group, a hydroxy C1-6 alkyl group, a C1-6 alkoxy group, an amino group, a C1-6 alkylamino group, a hydroxyamino group, an N—C1-6 alkylcarbamoyl group, or a group represented by the following formula (2): wherein R3 represents a C1-6 alkyl group, and R2 represents a hydrogen atom, a halogen atom, a C1-6 alkyl group, a C1-6 alkoxy group, or a carboxyl group. |
地址 |
Aichi JP |